Kenneth A. Stauderman - 24 Sep 2026 Form 4 Insider Report for CalciMedica, Inc. (CALC)

Reporting relationship: Chief Scientific Officer
Issuer ticker: CALC
Reported as of: 24 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 28 Sep 2026, 16:28:41 UTC
Prior SEC filing: 07 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ John Dunn, Attorney-in-Fact

Key filing fact

Kenneth A. Stauderman filed Form 4 for CalciMedica, Inc. (CALC) on 28 Sep 2026.

Key facts

This page summarizes Kenneth A. Stauderman's Form 4 filing for CalciMedica, Inc. (CALC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 28 Sep 2026, 16:28.

Change

Previous filing in this sequence was filed on 07 Apr 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001969388 Primary reporting owner

Stauderman Kenneth A.

Relationship: Chief Scientific Officer
Address: CALCIMEDICA, INC., 505 COAST S. BLVD. #307, LA JOLLA
Signature: /s/ John Dunn, Attorney-in-Fact
Signature date: 28 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CALC transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +180,000
Change %
Price: $0.000000^*
Shares after: 180,000
Date: 24 Sep 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 180,000
Exercise price: $1.74
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Beginning September 24, 2026, 1/48th of the shares subject to the option shall vest in equal monthly installments over a four year period.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .